Aidapak Recalls Lovastatin Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 20 mg Lovastatin tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly given the risk of patients receiving incorrect prescription medications.
Plain-English summary
Aidapak Services, LLC is recalling 300-tablet bottles of Lovastatin, 20 mg tablets, distributed under NDC 00185007201. The recall is due to a labeling error where the product may have been mislabeled as Aspirin EC DR 81 mg, Fluvastatin Sodium 20 mg, or Dutasteride 0.5 mg. The affected lots have pedigree codes AD28369_1, AD73597_10, and W003263, with expiration dates ranging from May 7, 2014, to June 17, 2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The FDA has classified this recall as Class II, indicating a situation that might cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Consumers and healthcare providers should stop using the affected Lovastatin tablets and contact their pharmacist or healthcare provider for a replacement. Patients should not switch to the potentially mislabeled drugs without medical guidance, as the incorrect medications may not be appropriate for their condition.
The recalled product
- Product
- LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- LOVASTATIN
- Tablet
- 20 mg has the following codes: Pedigree: AD28369_1
- EXP: 5/7/2014
- Pedigree: AD73597_10
- EXP: 5/31/2014
- Pedigree: W003263
- EXP: 6/17/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Simvastatin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Lubiprostone Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Losartan Potassium Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Isosorbide Mononitrate Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Olanzapine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereRivaroxaban Tablets Recalled for Potential Venlafaxine Labeling Error
FDA (Drugs) · 2014-01-22